CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,042,000 | +712.8% | 542,817 | +289.9% | 0.11% | +730.8% |
| Q2 2022 | $3,450,000 | -14.9% | 139,219 | -13.9% | 0.01% | +18.2% |
| Q1 2022 | $4,056,000 | -51.9% | 161,775 | -30.1% | 0.01% | -54.2% |
| Q4 2021 | $8,428,000 | +504.2% | 231,462 | +122.1% | 0.02% | +380.0% |
| Q2 2021 | $1,395,000 | -54.3% | 104,213 | +111.4% | 0.01% | -61.5% |
| Q4 2020 | $3,052,000 | +450.9% | 49,294 | +387.7% | 0.01% | +333.3% |
| Q3 2020 | $554,000 | -34.3% | 10,108 | -91.9% | 0.00% | -50.0% |
| Q3 2019 | $843,000 | – | 124,328 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |